Worldleish

An International Congress on Leishmania & Leishmaniasis

Why ?  Cutaneous, mucocutaneous and visceral leishmaniases are serious diseases, which are vector-borne and wide-spread in more than 90 countries, putting 350 million population at risk. WHO estimates an annual incidence of 2 million and a total of 12 million current cases. The causative agents are various species of trypanosomatid protozoa in the genus of Leishmania, which are excellent models for aspects of laboratory studied in cell/molecular biology, biochemistry, immunology of host-parasite interactions.

Who ? Anyone interested in Leishmania and leishmaniasis is welcome to participate, including individuals of private and public academic institutions, charitable organizations, advocacy groups, government officials/ representatives, for-profit private sectors and their friends/affiliates.

 When/where ? Every four years in a country endemic to leishmaniasis.

What ? Bring laboratory researchers and field workers from all disciplinary areas together for sharing new discoveries and exchange of new ideas. Provide opportunities of international collaboration, industrial participation, charitable donation and training of the next generation.

 


SECOND
WORLD CONGRESS ON LEISHMANIOSIS
20-24 May 2001, Crete, GREECE


ORGANIZED BY

UNIVERSITY OF CRETE

HELLENIC PASTEUR INSTITUTE

TURKISH SOCIETY for PARASITOLOGY

 

CONGRESS VENUE

Creta Maris Hotel, Hersonissos, Crete, Greece

 

ORGANIZING COMMITTEE

Presidents

M. Ali Ozcel, Ege University Medical Faculty, Turkey
Y. Tselentis, University of Crete, Greece

Honorary President   

C. Stournaras, General Director, Hellenic Pasteur Institute,Greece

Members      

M.Z. Alkan, Turkey,
K.-P Chang, U.S.A.,
K. Soteriadou, Greece

 

SCIENTIFIC COMMITTEE

K.-P. Chang (USA), P. Desjeux (Geneva), E. Handman (Australia), C. L. Jaffe (Israel), R. Killick-Kendrick (UK), H. Momen (Brasil), S. G. Reed (USA), K. Soteriadou (Greece), K. Stuart (USA)

Related Documents